Bilim Pharmaceuticals

bilim calisanlarının biraraya geldigi , resmi olmayan paylasım platformudur. Kurumu resmi olarak temsil etmemektedir. non-official sharing platform... ................................................................................................................................................................

Abdi Ibrahim Pharmaceuticals

Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi Nadir İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 250 brands and more than 500 products which it develops itself as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s Pharmaceutical Industry since 2002. Today, Abdi İbrahim, which operates in 17 countries outside Turkey, exports to more than 70 countries ranging from Canada to European Union member states, from North Africa to Asia and creates the highest employment with nearly 5.500 qualified employees in the Turkish pharmaceutical industry. The company also comes to the fore with its marketing and sales team, which is the largest in the industry. Abdi İbrahim, having the first accredited R&D center in the industry, is a role model with its technological equipment and architecture as well as R&D processes in healing the future. Abdi Ibrahim has an R&D Center, production facility for chemical products, Turkey's largest biotechnological manufacturing facility AbdiBio and hormone production area, ophthalmology production area which will be operational in 2019 and Sterile Injectable & Oncology production facility which will be operational in 2021 in Istanbul Esenyurt production complex. Abdi İbrahim has also R&D Centers and production facilities in Kazakhstan and Algeria. Abdi İbrahim has taken an important step by signing United Nations Global Principles Agreement in 2010 and given the opportunity to share high standards which it has acquired in the fields of human rights, as well as environmental and social responsibility. Besides, Abdi İbrahim has focused its activities on sustainability studies on level A of Global Reporting Initiative (GRI) and published its third Sustainability Report.

Sanovel İlaç

Founded in 1983 by Pharmacist Erol Toksöz, Sanovel stands as one of the leading pharmaceutical companies in Türkiye. Boasting an annual production capacity of 227 million units and EU GMP (Good Manufacturing Practices) certification, the company aspires to be a global pharmaceutical company. This vision is driven by robust R&D, an extensive product portfolio featuring over 60 brands and 180 products, and a dedicated team of over 1,600 individuals committed to fostering long and healthy lives. Distinguished as the first and only Turkish pharmaceutical company to be approved by the American Food and Drug Administration (FDA), acknowledged as the world's foremost health authority, Sanovel obtained approval without encountering any major or critical observations. With exceptional capabilities in terms of R&D, patents and intellectual property rights, Sanovel is the pioneering company to offer equivalent products to the market in a wide range of treatment areas. Sanovel R&D Center & Production Campus in İstanbul Silivri, started production in 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year. Enjoying a leadership position in intellectual property competence within the industry, Sanovel has consistently maintained its status as the patent champion of the Turkish pharmaceutical industry, a title attributable to the company's exceptional work in the realm of intellectual property. Guided by a strong vision, Sanovel centers its entire operation around sustainability, aiming for a balanced and valuable life for its hundreds of highly competent and passionate employees. Sanovel is dedicated to contributing to the Turkish pharmaceutical industry and the national economy, a commitment it has upheld for four decades, with the overarching goal of promoting a lifelong health worldwide.

Nobel Ilac A.S

Who are we? Nobel İlaç has been active in the international market with a national capital from 1964 until today and develops pioneer and novelist products which increases the life quality by using the resources productively with the principle of being a worldwide trustworthy organization. Nobel İlaç has been listed among the fastest growing 100 companies and holds the leadership in exportation among the Turkish medicinal firms. Such success of Nobel İlaç is based on product development, manufacturing and sales-marketing strategy conducted in Turkey and in the world. Nobel İlaç in Turkey and in the world: The headquarters of Nobel İlaç holding is in Ümraniye. Research and development activities are conducted in the manufacturing site and R&D center in Düzce. Drug raw material and micro pellet manufacturing is conducted In Ulkar Kimya in Çerkezköy. Besides the manufacturing sites in Turkey, Nobel İlaç has two more manufacturing sites in Kazakhstan and Uzbekistan. The world standard products manufactured in these facilities are presented to the surrounding countries. Our facility located in Kazakhstan is the largest of the Central Asia and is the first drug manufacturing facility receiving GMP in Kazakhstan. Our product portfolio is as follows: From 1964 until today, Nobel İlaç has provided quality and affordable drug alternatives to the Turkish people and to the world, which is still active inside and outside the country with almost 100 products. Such products can be grouped as follows: • Painkillers and rheumatism drugs • Antibiotics and fungicides • Cold drugs • Digestion system drugs • Urinary system drugs • Cardiovascular system drugs • Central nervous system drugs • Supplementary nutrients such as probiotics, fish oils • Vitamins and mineral supplements for empowering the immune system, products for bone joints and cartilage health, hair-nail and skin health products, cosmetics, personal hygiene and care products.

WORLD MEDICINE TÜRKİYE

World Medicine Ilac Sanayi ve Ticaret Anonim Sirketi was established in Turkey in 2011 as an affiliate of the Corporate Group of World Medicine. The company aims to improve the quality of life by providing accessible and effective products worldwide by adopting an innovative perspective in line with sustainable quality standards. Aiming to be a reliable business partner and leading company in all countries and fields in which it operates, World Medicine maintains its activities with a wide portfolio of more than 450 pharmacological products in the fields of ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology, pulmonology, etc. World Medicine, which exports medicines to more than 50 countries, has its headquarters in Turkey and its R&D laboratory with advanced technical devices is located in Istanbul. One of its domestic production facilities is operating in Istanbul and the others in Tekirdag- Cerkezkoy. The company's production facilities abroad operate in Romania and Algeria.